Intranasal Insulin Promising for MCI, Alzheimer’s Disease
From Medscape News Today – by Megan Brooks September 13, 2011 — In a pilot study, a nasal spray form of insulin, used daily for 4 months, stabilized or improved cognition, function, and cerebral glucose metabolism in adults with amnestic mild cognitive impairment (aMCI) and mild to moderate Alzheimer’s disease (AD). “Taken together, these results … Read more